3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma, Follicular
2
Lymphoma, B-Cell
2
Xanthogranuloma, Juvenile
1
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma, Ewing
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Medulloblastoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Histiocytosis, Langerhans-Cell
1
Histiocytic Sarcoma
1
Hepatoblastoma
1
Glioma
1
Ependymoma
1
Central Nervous System Neoplasms
1
Carcinoma, Transitional Cell
1
Interventions
Rituximab
13
acalabrutinib
9
Cyclophosphamide
9
zanubrutinib
7
ibrutinib
7
CT-P10
7
Magnetic Resonance Spectroscopy
6
Cytarabine
5
venetoclax
4
fludarabine
4
Specimen Handling
4
Cyclosporine
4
obinutuzumab
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Vincristine
3
Stem Cell Transplantation
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Methotrexate
3
Lenalidomide
3
Doxorubicin
3
Biopsy
3
Bendamustine Hydrochloride
3
pirtobrutinib
2
merphos
2
dexamethasone acetate
2
dexamethasone 21-phosphate
2
auricularum
2
Sirolimus
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Mantle-Cell
×
tazemetostat
×
30 days
×
Clear all
No trials found.